- Home
- CDLX vs XBIT Comparison
CDLX vs XBIT Comparison
Compare CDLX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLX
- XBIT
- Stock Information
- Founded
- CDLX 2008
- XBIT 2005
- Country
- CDLX United States
- XBIT United States
- Employees
- CDLX N/A
- XBIT N/A
- Industry
- CDLX Computer Software: Programming Data Processing
- XBIT Pharmaceuticals and Biotechnology
- Sector
- CDLX Technology
- XBIT Health Care
- Exchange
- CDLX Nasdaq
- XBIT Nasdaq
- Market Cap
- CDLX 180.4M
- XBIT 194.5M
- IPO Year
- CDLX 2018
- XBIT 2015
- Fundamental
- Price
- CDLX $2.98
- XBIT $3.25
- Analyst Decision
- CDLX Hold
- XBIT
- Analyst Count
- CDLX 6
- XBIT 0
- Target Price
- CDLX $5.90
- XBIT N/A
- AVG Volume (30 Days)
- CDLX 979.5K
- XBIT 52.0K
- Earning Date
- CDLX 03-13-2025
- XBIT 03-14-2025
- Dividend Yield
- CDLX N/A
- XBIT N/A
- EPS Growth
- CDLX N/A
- XBIT N/A
- EPS
- CDLX N/A
- XBIT N/A
- Revenue
- CDLX $293,468,000.00
- XBIT N/A
- Revenue This Year
- CDLX N/A
- XBIT N/A
- Revenue Next Year
- CDLX $3.49
- XBIT N/A
- P/E Ratio
- CDLX N/A
- XBIT N/A
- Revenue Growth
- CDLX N/A
- XBIT N/A
- 52 Week Low
- CDLX $2.76
- XBIT $3.25
- 52 Week High
- CDLX $20.52
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- CDLX 36.80
- XBIT 26.88
- Support Level
- CDLX $2.76
- XBIT $3.40
- Resistance Level
- CDLX $4.05
- XBIT $3.69
- Average True Range (ATR)
- CDLX 0.26
- XBIT 0.20
- MACD
- CDLX -0.04
- XBIT 0.05
- Stochastic Oscillator
- CDLX 10.69
- XBIT 3.85
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.